Cue Biopharma Inc
(CUE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 704 | 1,075 | 900 | 1,049 | 984 |
| Gross Profit | 704 | 1,075 | 900 | 1,049 | 984 |
| Operating Expenses | 10,835 | 12,017 | 13,895 | 10,067 | 8,078 |
| Operating Income | -10,131 | -10,942 | -12,995 | -9,017 | -7,094 |
| Other Income | 100 | 109 | 177 | 97 | 104 |
| Pre-tax Income | -10,031 | -10,833 | -12,818 | -8,921 | -6,990 |
| Income Tax | N/A | N/A | N/A | -1 | N/A |
| Net Income Continuous | -10,031 | -10,833 | -12,818 | -8,920 | -6,990 |
| Net Income | $-10,031 | $-10,833 | $-12,818 | $-8,920 | $-6,990 |
| EPS Basic Total Ops | -0.34 | -0.38 | -0.48 | -0.35 | -0.31 |
| EPS Basic Continuous Ops | -0.34 | -0.38 | -0.48 | -0.35 | -0.31 |
| EPS Diluted Total Ops | -0.34 | -0.38 | -0.48 | -0.35 | -0.31 |
| EPS Diluted Continuous Ops | -0.34 | -0.38 | -0.48 | -0.35 | -0.31 |
| EBITDA(a) | $-9,840 | $-10,615 | $-12,732 | $-8,884 | $-6,899 |